Related Experiment Videos
Leiomyoma recurrence after uterine artery embolization
Henri Marret1, Ana Maria Alonso, Jean Philippe Cottier
1Département de Gynécologie, Obstétrique, Médecine Foetale et Reproduction Humaine, Hôpital Bretonneau, Tours cedex, France. h.marret@chu-tours.fr
Journal of Vascular and Interventional Radiology : JVIR
|November 8, 2003
Summary
Uterine artery embolization (UAE) effectively treats symptomatic uterine fibroids, but a 10% recurrence rate was observed within two years. Continued monitoring is essential to track fibroid progression and identify recurrence risk factors.
Area of Science:
- Interventional Radiology
- Gynecologic Oncology
- Vascular Surgery
Background:
- Uterine artery embolization (UAE) is a minimally invasive treatment for symptomatic uterine fibroids.
- Evaluating long-term fibroid recurrence rates after UAE is crucial for patient management.
Observation:
- A prospective study assessed fibroid recurrence after UAE in 85 patients between 1997 and 2000.
- Median follow-up was 30 months, with clinical and ultrasound examinations conducted regularly.
- Immediate and late failures were recorded, including technical issues, concomitant diseases, and new fibroid development.
Findings:
- The study reported a 10% recurrence rate of uterine fibroids more than two years after UAE.
- Mean time to recurrence was 27.4 months, with most recurrences attributed to new fibroid growth.
- Immediate failures occurred in 7% of cases, while late failures/recurrences were observed in 9% of patients.
Implications:
- UAE is an effective primary treatment for uterine fibroids, but recurrence necessitates long-term surveillance.
- Pre-procedural screening for pedunculated submucosal fibroids and cancers is recommended.
- Extended follow-up beyond two years is vital for monitoring fibroid recurrence and identifying at-risk patients.